Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Acute vascular effects of vascular endothelial growth factor inhibition in the forearm arterial circulation.

Cameron AC, Welsh P, Neves KB, Newby DE, Touyz RM, Lang NN.

J Hypertens. 2019 Aug 19. doi: 10.1097/HJH.0000000000002230. [Epub ahead of print]

PMID:
31449168
2.

Response by Welsh et al to Letter Regarding Article "Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease".

Welsh CE, Welsh P, Jhund P, Sattar N, Mark PB.

Hypertension. 2019 Aug;74(2):e27-e28. doi: 10.1161/HYPERTENSIONAHA.119.13349. Epub 2019 Jun 24. No abstract available.

PMID:
31230548
3.

Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.

Welsh C, Celis-Morales CA, Brown R, Mackay DF, Lewsey J, Mark PB, Gray SR, Ferguson LD, Anderson JJ, Lyall DM, Cleland JG, Jhund PS, Gill JMR, Pell JP, Sattar N, Welsh P.

Circulation. 2019 Aug 13;140(7):542-552. doi: 10.1161/CIRCULATIONAHA.119.041149. Epub 2019 Jun 20.

4.

The association of grip strength with health outcomes does not differ if grip strength is used in absolute or relative terms: a prospective cohort study.

Ho FKW, Celis-Morales CA, Petermann-Rocha F, Sillars A, Welsh P, Welsh C, Anderson J, Lyall DM, Mackay DF, Sattar N, Gill JMR, Pell JP, Gray SR.

Age Ageing. 2019 Jun 17. pii: afz068. doi: 10.1093/ageing/afz068. [Epub ahead of print]

PMID:
31204772
5.

Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction.

Maznyczka AM, Carrick D, Carberry J, Mangion K, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, Watkins S, Davie A, Mahrous A, Ford I, Welsh P, Sattar N, Oldroyd KG, Berry C.

Open Heart. 2019 Apr 29;6(1):e000979. doi: 10.1136/openhrt-2018-000979. eCollection 2019.

6.

Do physical activity, commuting mode, cardiorespiratory fitness and sedentary behaviours modify the genetic predisposition to higher BMI? Findings from a UK Biobank study.

Celis-Morales CA, Lyall DM, Petermann F, Anderson J, Ward J, Iliodromiti S, Mackay DF, Welsh P, Bailey MES, Pell J, Sattar N, Gill JMR, Gray SR.

Int J Obes (Lond). 2019 Aug;43(8):1526-1538. doi: 10.1038/s41366-019-0381-5. Epub 2019 Jun 5.

PMID:
31168053
7.

Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank.

Ferguson LD, Brown R, Celis-Morales C, Welsh P, Lyall DM, Pell JP, McInnes IB, Siebert S, Sattar N.

Rheumatology (Oxford). 2019 May 25. pii: kez192. doi: 10.1093/rheumatology/kez192. [Epub ahead of print]

PMID:
31131407
8.

Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease.

Welsh CE, Welsh P, Jhund P, Delles C, Celis-Morales C, Lewsey JD, Gray S, Lyall D, Iliodromiti S, Gill JMR, Sattar N, Mark PB.

Hypertension. 2019 Jun;73(6):1202-1209. doi: 10.1161/HYPERTENSIONAHA.119.12726.

PMID:
31067194
9.

Cardiac Troponin T and Troponin I in the General Population.

Welsh P, Preiss D, Hayward C, Shah ASV, McAllister D, Briggs A, Boachie C, McConnachie A, Padmanabhan S, Welsh C, Woodward M, Campbell A, Porteous D, Mills NL, Sattar N.

Circulation. 2019 Jun 11;139(24):2754-2764. doi: 10.1161/CIRCULATIONAHA.118.038529. Epub 2019 Apr 24.

10.

The Combination of Physical Activity and Sedentary Behaviors Modifies the Genetic Predisposition to Obesity.

Celis-Morales CA, Lyall DM, Bailey MES, Petermann-Rocha F, Anderson J, Ward J, Mackay DF, Welsh P, Pell JP, Sattar N, Gill JMR, Gray SR.

Obesity (Silver Spring). 2019 Apr;27(4):653-661. doi: 10.1002/oby.22417.

PMID:
30900409
11.

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.

Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Welsh P, Kean S, Ford I, McConnachie A, Messow CM, Sattar N, Taylor R.

Lancet Diabetes Endocrinol. 2019 May;7(5):344-355. doi: 10.1016/S2213-8587(19)30068-3. Epub 2019 Mar 6.

PMID:
30852132
12.

High-throughput quantification of carboxymethyl lysine in serum and plasma using high-resolution accurate mass Orbitrap mass spectrometry.

Rankin NJ, Burgess K, Weidt S, Wannamethee G, Sattar N, Welsh P.

Ann Clin Biochem. 2019 May;56(3):397-407. doi: 10.1177/0004563219830432. Epub 2019 Mar 4.

13.

Dose-response associations of cardiorespiratory fitness with all-cause mortality and incidence and mortality of cancer and cardiovascular and respiratory diseases: the UK Biobank cohort study.

Steell L, Ho FK, Sillars A, Petermann-Rocha F, Li H, Lyall DM, Iliodromiti S, Welsh P, Anderson J, MacKay DF, Pell JP, Sattar N, Gill JM, Gray SR, Celis-Morales CA.

Br J Sports Med. 2019 Nov;53(21):1371-1378. doi: 10.1136/bjsports-2018-099093. Epub 2019 Feb 22.

PMID:
30796106
14.

Systemic Inflammation and Cardio-Renal Organ Damage Biomarkers in Middle Age Are Associated With Physical Capability Up to 9 Years Later.

Kuh D, Cooper R, Sattar N, Welsh P, Hardy R, Ben-Shlomo Y.

Circulation. 2019 Apr 23;139(17):1988-1999. doi: 10.1161/CIRCULATIONAHA.118.037332.

15.

Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.

McCartney PJ, Eteiba H, Maznyczka AM, McEntegart M, Greenwood JP, Muir DF, Chowdhary S, Gershlick AH, Appleby C, Cotton JM, Wragg A, Curzen N, Oldroyd KG, Lindsay M, Rocchiccioli JP, Shaukat A, Good R, Watkins S, Robertson K, Malkin C, Martin L, Gillespie L, Ford TJ, Petrie MC, Macfarlane PW, Tait RC, Welsh P, Sattar N, Weir RA, Fox KA, Ford I, McConnachie A, Berry C; T-TIME Group.

JAMA. 2019 Jan 1;321(1):56-68. doi: 10.1001/jama.2018.19802.

16.

Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.

Sabater-Lleal M, Huffman JE, de Vries PS, Marten J, Mastrangelo MA, Song C, Pankratz N, Ward-Caviness CK, Yanek LR, Trompet S, Delgado GE, Guo X, Bartz TM, Martinez-Perez A, Germain M, de Haan HG, Ozel AB, Polasek O, Smith AV, Eicher JD, Reiner AP, Tang W, Davies NM, Stott DJ, Rotter JI, Tofler GH, Boerwinkle E, de Maat MPM, Kleber ME, Welsh P, Brody JA, Chen MH, Vaidya D, Soria JM, Suchon P, van Hylckama Vlieg A, Desch KC, Kolcic I, Joshi PK, Launer LJ, Harris TB, Campbell H, Rudan I, Becker DM, Li JZ, Rivadeneira F, Uitterlinden AG, Hofman A, Franco OH, Cushman M, Psaty BM, Morange PE, McKnight B, Chong MR, Fernandez-Cadenas I, Rosand J, Lindgren A; INVENT Consortium; MEGASTROKE Consortium of the International Stroke Genetics Consortium (ISGC), Gudnason V, Wilson JF, Hayward C, Ginsburg D, Fornage M, Rosendaal FR, Souto JC, Becker LC, Jenny NS, März W, Jukema JW, Dehghan A, Trégouët DA, Morrison AC, Johnson AD, O'Donnell CJ, Strachan DP, Lowenstein CJ, Smith NL.

Circulation. 2019 Jan 29;139(5):620-635. doi: 10.1161/CIRCULATIONAHA.118.034532.

17.

Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment.

Sliz E, Kettunen J, Holmes MV, Williams CO, Boachie C, Wang Q, Männikkö M, Sebert S, Walters R, Lin K, Millwood IY, Clarke R, Li L, Rankin N, Welsh P, Delles C, Jukema JW, Trompet S, Ford I, Perola M, Salomaa V, Järvelin MR, Chen Z, Lawlor DA, Ala-Korpela M, Danesh J, Davey Smith G, Sattar N, Butterworth A, Würtz P.

Circulation. 2018 Nov 27;138(22):2499-2512. doi: 10.1161/CIRCULATIONAHA.118.034942. Epub 2018 Aug 15.

PMID:
30524137
18.

Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment

Sliz E, Kettunen J, Holmes MV, Williams CO, Boachie C, Wang Q, Männikkö M, Sebert S, Walters R, Lin K, Millwood LY, Clarke R, Li L, Rankin N, Welsh P, Delles C, Jukema JW, Trompet S, Ford I, Perola M, Salomaa V, Järvelin MR, Chen Z, Lawlor DA, Ala-Korpela M, Danesh J, Smith GD, Sattar N, Butterworth A, Würtz P.

Circulation. 2018 Nov 27;138(22):2499–2512.

19.

Walking Pace Is Associated with Lower Risk of All-Cause and Cause-Specific Mortality.

Celis-Morales CA, Gray S, Petermann F, Iliodromiti S, Welsh P, Lyall DM, Anderson J, Pellicori P, Mackay DF, Pell JP, Sattar N, Gill JMR.

Med Sci Sports Exerc. 2019 Mar;51(3):472-480. doi: 10.1249/MSS.0000000000001795.

PMID:
30303933
20.

Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort.

Welsh P, Preiss D, Shah ASV, McAllister D, Briggs A, Boachie C, McConnachie A, Hayward C, Padmanabhan S, Welsh C, Woodward M, Campbell A, Porteous D, Mills NL, Sattar N.

Clin Chem. 2018 Nov;64(11):1607-1616. doi: 10.1373/clinchem.2018.292086. Epub 2018 Aug 20.

21.

High-Sensitivity Troponin T and Incident Heart Failure in Older Men: British Regional Heart Study.

Welsh P, Papacosta O, Ramsay S, Whincup P, McMurray J, Wannamethee G, Sattar N.

J Card Fail. 2019 Apr;25(4):230-237. doi: 10.1016/j.cardfail.2018.08.002. Epub 2018 Aug 11.

22.

Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.

Haig C, Carrick D, Carberry J, Mangion K, Maznyczka A, Wetherall K, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, Watkins S, Davie A, Mahrous A, Mordi I, Ahmed N, Teng Yue May V, Ford I, Radjenovic A, Welsh P, Sattar N, Oldroyd KG, Berry C.

JACC Cardiovasc Imaging. 2019 Jun;12(6):993-1003. doi: 10.1016/j.jcmg.2018.05.022. Epub 2018 Jul 18.

23.

Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction.

Carrick D, Haig C, Maznyczka AM, Carberry J, Mangion K, Ahmed N, Yue May VT, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, Watkins S, Davie A, Mahrous A, Mordi I, Ford I, Radjenovic A, Welsh P, Sattar N, Wetherall K, Oldroyd KG, Berry C.

Hypertension. 2018 Sep;72(3):720-730. doi: 10.1161/HYPERTENSIONAHA.117.10786.

24.

Associations of Dietary Protein Intake With Fat-Free Mass and Grip Strength: A Cross-Sectional Study in 146,816 UK Biobank Participants.

Celis-Morales CA, Petermann F, Steell L, Anderson J, Welsh P, Mackay DF, Iliodromiti S, Lyall DM, Lean ME, Pell JP, Sattar N, Gill JMR, Gray SR.

Am J Epidemiol. 2018 Nov 1;187(11):2405-2414. doi: 10.1093/aje/kwy134.

PMID:
29961893
25.

Metformin, lipids and atherosclerosis prevention.

Jenkins AJ, Welsh P, Petrie JR.

Curr Opin Lipidol. 2018 Aug;29(4):346-353. doi: 10.1097/MOL.0000000000000532. Review.

PMID:
29878903
26.

Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.

Colombo M, Looker HC, Farran B, Agakov F, Brosnan MJ, Welsh P, Sattar N, Livingstone S, Durrington PN, Betteridge DJ, McKeigue PM, Colhoun HM.

Atherosclerosis. 2018 Jul;274:182-190. doi: 10.1016/j.atherosclerosis.2018.05.014. Epub 2018 May 25.

27.

Associations of discretionary screen time with mortality, cardiovascular disease and cancer are attenuated by strength, fitness and physical activity: findings from the UK Biobank study.

Celis-Morales CA, Lyall DM, Steell L, Gray SR, Iliodromiti S, Anderson J, Mackay DF, Welsh P, Yates T, Pell JP, Sattar N, Gill JMR.

BMC Med. 2018 May 24;16(1):77. doi: 10.1186/s12916-018-1063-1.

28.

Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants.

Celis-Morales CA, Welsh P, Lyall DM, Steell L, Petermann F, Anderson J, Iliodromiti S, Sillars A, Graham N, Mackay DF, Pell JP, Gill JMR, Sattar N, Gray SR.

BMJ. 2018 May 8;361:k1651. doi: 10.1136/bmj.k1651.

29.

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.

Welsh P, Rankin N, Li Q, Mark PB, Würtz P, Ala-Korpela M, Marre M, Poulter N, Hamet P, Chalmers J, Woodward M, Sattar N.

Diabetologia. 2018 Jul;61(7):1581-1591. doi: 10.1007/s00125-018-4619-x. Epub 2018 May 4.

30.

The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent.

Iliodromiti S, Celis-Morales CA, Lyall DM, Anderson J, Gray SR, Mackay DF, Nelson SM, Welsh P, Pell JP, Gill JMR, Sattar N.

Eur Heart J. 2018 May 1;39(17):1514-1520. doi: 10.1093/eurheartj/ehy057.

31.

Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank.

Welsh C, Welsh P, Mark PB, Celis-Morales CA, Lewsey J, Gray SR, Lyall DM, Iliodromiti S, Gill JMR, Pell J, Jhund PS, Sattar N.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1415-1423. doi: 10.1161/ATVBAHA.118.310945. Epub 2018 Apr 26.

PMID:
29699973
32.

A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease.

Bodde MC, Welsh P, Bergheanu SC, Lijfering WM, Mertens B, Liem AH, van der Laarse A, Sattar N, Jukema JW.

Clin Pharmacol Ther. 2018 Aug;104(2):311-316. doi: 10.1002/cpt.1095. Epub 2018 May 15.

PMID:
29672821
33.

Objectively measured physical activity and cardiac biomarkers: A cross sectional population based study in older men.

Parsons TJ, Sartini C, Welsh P, Sattar N, Ash S, Lennon LT, Wannamethee SG, Lee IM, Whincup PH, Jefferis BJ.

Int J Cardiol. 2018 Mar 1;254:322-327. doi: 10.1016/j.ijcard.2017.11.003. Epub 2018 Jan 28.

34.

Correlating Changes in Metabolic Status With Arterial Health: Modest Associations but Any Clinical Implications?

Welsh P.

Hypertension. 2018 Feb;71(2):227-228. doi: 10.1161/HYPERTENSIONAHA.117.10595. Epub 2017 Dec 26. No abstract available.

PMID:
29279313
35.

Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment-Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications.

Carberry J, Carrick D, Haig C, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Davie A, Mahrous A, Ford I, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C.

Circ Cardiovasc Imaging. 2017 Dec;10(12). pii: e006586. doi: 10.1161/CIRCIMAGING.117.006586.

36.

The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation.

Stoumpos S, Lees J, Welsh P, Hund M, Geddes CC, Nelson SM, Mark PB.

Reprod Biomed Online. 2018 Feb;36(2):219-226. doi: 10.1016/j.rbmo.2017.11.003. Epub 2017 Nov 28.

PMID:
29233504
37.

Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997.

Delles C, Rankin NJ, Boachie C, McConnachie A, Ford I, Kangas A, Soininen P, Trompet S, Mooijaart SP, Jukema JW, Zannad F, Ala-Korpela M, Salomaa V, Havulinna AS, Welsh P, Würtz P, Sattar N.

Eur J Heart Fail. 2018 Apr;20(4):663-673. doi: 10.1002/ejhf.1076. Epub 2017 Dec 11.

38.

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.

Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R.

Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5.

PMID:
29221645
39.

Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.

Taylor R, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Sattar N, Welsh P, Peters C, Zhyzhneuskaya S, Hollingsworth KG, Al-Mrabeh A, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Kean S, Ford I, McConnachie A, Lean MEJ.

Diabetologia. 2018 Mar;61(3):589-598. doi: 10.1007/s00125-017-4503-0. Epub 2017 Nov 30.

40.

Effect of non-surgical weight management on weight and glycaemic control in people with type 2 diabetes: A comparison of interventional and non-interventional outcomes at 3 years.

Botha S, Forde L, MacNaughton S, Shearer R, Lindsay R, Sattar N, Morrison D, Welsh P, Logue J.

Diabetes Obes Metab. 2018 Apr;20(4):879-888. doi: 10.1111/dom.13171. Epub 2018 Jan 11.

PMID:
29178635
41.

Persistent Iron Within the Infarct Core After ST-Segment Elevation Myocardial Infarction: Implications for Left Ventricular Remodeling and Health Outcomes.

Carberry J, Carrick D, Haig C, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Davie A, Mahrous A, Ford I, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C.

JACC Cardiovasc Imaging. 2018 Sep;11(9):1248-1256. doi: 10.1016/j.jcmg.2017.08.027. Epub 2017 Nov 15.

42.

Cord Metabolic Profiles in Obese Pregnant Women: Insights Into Offspring Growth and Body Composition.

Patel N, Hellmuth C, Uhl O, Godfrey K, Briley A, Welsh P, Pasupathy D, Seed PT, Koletzko B, Poston L; UPBEAT Consortium.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):346-355. doi: 10.1210/jc.2017-00876.

43.

Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study.

Sartini C, Whincup PH, Wannamethee SG, Jefferis BJ, Lennon L, Lowe GD, Welsh P, Sattar N, Morris RW.

BMJ Open. 2017 Nov 12;7(11):e018264. doi: 10.1136/bmjopen-2017-018264.

44.

Prediction of uncomplicated pregnancies in obese women: a prospective multicentre study.

Vieira MC, White SL, Patel N, Seed PT, Briley AL, Sandall J, Welsh P, Sattar N, Nelson SM, Lawlor DA, Poston L, Pasupathy D; UPBEAT Consortium.

BMC Med. 2017 Nov 3;15(1):194. doi: 10.1186/s12916-017-0956-8.

45.

Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study.

Rutherford E, Mangion K, McComb C, Bell E, Cockburn S, Talle M, Roditi G, Welsh P, Woodward R, Radjenovic A, Struthers AD, Jardine AG, Berry C, Patel RK, Mark PB.

Sci Rep. 2017 Oct 25;7(1):13976. doi: 10.1038/s41598-017-14481-y.

46.

Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study.

Celis-Morales CA, Petermann F, Hui L, Lyall DM, Iliodromiti S, McLaren J, Anderson J, Welsh P, Mackay DF, Pell JP, Sattar N, Gill JMR, Gray SR.

Diabetes Care. 2017 Dec;40(12):1710-1718. doi: 10.2337/dc17-0921. Epub 2017 Oct 6.

PMID:
28986505
47.

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.

Welsh P, Kou L, Yu C, Anand I, van Veldhuisen DJ, Maggioni AP, Desai AS, Solomon SD, Pfeffer MA, Cheng S, Gullestad L, Aukrust P, Ueland T, Swedberg K, Young JB, Kattan MW, Sattar N, McMurray JJV.

Eur J Heart Fail. 2018 Feb;20(2):268-277. doi: 10.1002/ejhf.988. Epub 2017 Sep 27.

48.

Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.

Price AH, Weir CJ, Welsh P, McLachlan S, Strachan MWJ, Sattar N, Price JF.

Atherosclerosis. 2017 Sep;264:67-73. doi: 10.1016/j.atherosclerosis.2017.07.009. Epub 2017 Jul 12.

49.

Metabolic profiling of gestational diabetes in obese women during pregnancy.

White SL, Pasupathy D, Sattar N, Nelson SM, Lawlor DA, Briley AL, Seed PT, Welsh P, Poston L; UPBEAT Consortium.

Diabetologia. 2017 Oct;60(10):1903-1912. doi: 10.1007/s00125-017-4380-6. Epub 2017 Aug 1.

50.

Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes.

Wannamethee SG, Welsh P, Papacosta O, Ellins EA, Halcox JPJ, Whincup PH, Sattar N.

Atherosclerosis. 2017 Sep;264:36-43. doi: 10.1016/j.atherosclerosis.2017.07.008. Epub 2017 Jul 12.

Supplemental Content

Loading ...
Support Center